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RNA binding protein QKIHearts of diabetic individuals are susceptible to ischemia/reperfusion (I/R) injury. The RNA-binding protein Quaking
(QKI) is known to link intracellular signaling to cellular survival andQKI dysregulationmay contribute to humandis-
eases. However, the function of QKI in diabetic hearts remains unknown. The current study attempted to identify
newmolecularmechanisms that potentially contribute to the susceptibility to ischemic injury in diabeticmyocardi-
um. Diabetic ob/obmice orwild-type C57BL/6Jmicewere subjected to in vivomyocardial I/R.Myocardial infarct size
and apoptosis, QKI5 and FoxO1 expression, nitrosative stress (NS) and ER stress were compared. Knockdown of
FoxO1was obtained by intramyocardial injection of FoxO1 speciﬁc small interfering RNA (siRNA, 20 μg), and upreg-
ulation of QKI5 was acquired by injecting adenovirus encoding-QKI5. Obvious NS stress was observed in the myo-
cardium of ob/ob mice represented by elevated iNOS expression, total NO content and nitrotyrosine content.
Administration of 1400W or M40401 partly reduced the caspase-3 activity in ob/obmyocardium encountering I/R
(P b 0.05). Higher ER stress was also observed represented by increased p-PERK, p-eIF2α and expression of CHOP
in ob/ob myocardium. ER stress inhibitor did not affect the excessive NS stress, but partially reduced I/R-
induced caspase-3 activity in ob/ob hearts (P b 0.05). FoxO1 was overactivated in ob/ob myocardium, and
knockdown of FoxO1 attenuated both levels of NS stress and ER stress (P b 0.05). Furthermore, QKI5 expres-
sion was deﬁcient in ob/obmyocardium. Upregulation of QKI5 diminished FoxO1 expression together with
NS and ER stress in ob/ob myocardium, further reducing MI/R injury. Finally, QKI5 overexpression
destabilized FoxO1 mRNA in cardiomyocytes. These results suggested that QKI5 deﬁciency contributed to
the overactivation of FoxO1 in ob/ob animals and subsequently magniﬁed nitrosative stress and ER stress,
which enhances the ischemic intolerance of diabetic hearts.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Epidemiologic studies have demonstrated that diabetes mellitus
(DM) contributes to more than 3 million cardiovascular deaths
worldwide each year. Type 2 diabetes mellitus (T2D) is the predomi-
nant prevalent DM. Experimental and clinical data demonstrated that
the cardiovascular dysfunction caused by T2D directly and indirectly
aggravates ischemic heart injury, which results in larger infarct size
and more severe heart failure after myocardial ischemia [1,2]. These
available evidences strongly support the notion that patients with T2Dlogy, Tangdu Hospital, Fourth
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g), hengma@fmmu.edu.cn
. This is an open access article underhave higher mortality after acute myocardial infarction (AMI) than
non-diabetic patients [3,4]. However, the core molecular mechanism
of the susceptibility to ischemia/reperfusion (I/R) injury in diabetic
hearts is still to be determined.
Nitrosative stress is namely intracellular protein nitration induced
by peroxynitrite (ONOO−), a reaction product of nitric oxide (NO−)
and superoxide (O2−). Tao et al. found that iNOS-derived reactive
nitrogen species and resultant nitrosative stress increase the sensitivity
of the heart to I/R injury [5]. Furthermore, interventions that inhibited
iNOS activity or scavenged peroxynitrite reduced nitrosative stress
and attenuated tissue injury [6,7]. Besides, perturbations of ER function
cause endoplasmic reticulum(ER) stress leading to the unfoldedprotein
response (UPR), which includes the inhibition of protein synthesis,
protein refolding and clearance of misfolded proteins [8]. The UPR
favors cellular homeostasis; however, prolonged ER stress can trigger
apoptosis [9]. Large amounts of studies have shown that severe ER
stress results in cardiomyocyte apoptosis in vivo and in vitro [10–12].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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cluding apoptosis [11,13–15]. Identifying the cellular and molecular
basis that links nitrosative or ER stress with the vulnerability to MI/R
injury may reveal new therapeutic approaches for cardiovascular
diseases related to diabetes.
Forkhead box O1 (FoxO1) is a critical transcription factor that plays
an important role in regulating cellular metabolism, proliferation,
oxidative stress response, immune homeostasis and cell death [16].
Recent studies have found that FoxO1 might play important roles in
cardiovascular diseases including diabetes [17,18]. Pathological
conditions such as obesity, insulin resistance, and diabetes lead to
unregulated activation of FoxO1, which can result in metabolic distur-
bances and cell death pathway activation. It was also reported that
FoxO1 could activate the expression of iNOS and mediate cardiomyo-
cyte apoptosis [17,18]. However, the molecular regulation mechanisms
responsible for FoxO1 in diabetes mellitus have not been fully identi-
ﬁed. Yu et al. found that RNA binding protein QKI has posttranscription-
al regulation on FoxO1 in breast cancer cells [19]. Our previous study
suggested that QKI5 was a cardiac endogenous protective protein that
inhibited apoptosis. More importantly, we also found that FoxO1 was
one of target genes inhibited by QKI5 in cultured cardiomyocytes [20].
Here, we hypothesize that QKI5 dysfunction promotes FoxO1
overactivation mediated myocardial cell death and increases the
vulnerability to ischemic injury in diabetic heart.
2. Materials and methods
2.1. Animals
Male leptin-deﬁcient (ob/ob) mice and their wild-type (WT) C57BL/6
mice were purchased from theModel Animal Research Center of Nanjing
University (Nanjing, China, AAALAC accredited) at ages of 8–10 weeks
and utilized at ages of 12 weeks in this study. The ob/obmice were fed
normal chow diet, and sex matched wild-type mice served as controls.
The experiments were performed in adherence with the National
Institutes of Health Guidelines on the Use of Laboratory Animals and
were approved by the Fourth Military Medical University Committee on
Animal Care.
2.2. Experimental protocols
Mice were anesthetized with 2% isoﬂurane, and myocardial
infarction (MI) was induced as described in our previous studies
[21]. After 30min ofMI, the slipknotwas released, and themyocardium
was reperfused (R) for 4 h or 24 h (cardiac function only). Blood sam-
ples (1 ml) were drawn after 4-hour reperfusion. Lactate
dehydrogenase (LDH) was spectrophotometrically assayed using a
kit from Sigma Chemical Co. To investigate the effects of nitrosative
inhibitors on I/R injury of ob/obmyocardium, 10 min before reperfusion,
ob/ob mice were randomized to receive either vehicle (PBS, pH 7.5),
1400W(2 mg/kg), orM40401 (0.25 mg/kg) by i.p. injection [6]. To inves-
tigate the effect of salubrinal (SAL) on the I/R injury of ob/obmyocardium,
ob/obmicewere randomized to receive either vehicle (PBS, pH7.5) or SAL
(1 mg/kg) [22] by i.p. injection 10 min before reperfusion. To investigate
the effects of FoxO1 downregulation, FoxO1 speciﬁc siRNA (against
murine) contains the targeting sequence 5′-GAGCGTGCCCTACTTC
AAG-3′, which targets to a coding region of mouse FoxO1 gene
(GenePharma, Shanghai, China). 20 μg of FoxO1 siRNA or scrambled
siRNA was diluted in 30 μl of vivo-jetPEITM (Invitrogen, USA) and
10% glucose mixture. 30 μl of vehicle, scrambled siRNA, or FoxO1
siRNA solutionwas delivered via six separate intramyocardial injections
(5 μl per injection) into the left ventricle apex and anterolateral wall
using a 30-gauge needle [21,23]. After 48 h of siRNA or vehicle injection
in hearts, mice were subjected to cardiac surgery (MI/R). To study the
role of QKI5 overexpression, ob/ob mice were randomized to receive
myocardium injection of either vehicle (PBS, pH 7.5), 2 × 108 plaqueforming units of Ad-QKI5 or control adenovirus (Ad-EGFP) 48 h before
I/R treatment [20]. Normal C57BL/6J (WT) mice were used as control
animals. Full-length QKI5 cDNAwas inserted to pcDNA3.1 (+), produc-
ing QKI5 expression plasmid. Recombinant adenoviruses encoding
these genes were generated via an AdEasy adenovirus construction kit
following the manufacturer's instruction. Viral supernatants were
clariﬁed by centrifugation and titered by plaque assays. Aliquots of
virus were stored frozen at−80 °C.
2.3. Intraperitoneal glucose tolerance test (IPGTT)
After a 16 h fast, alert mice were challenged with a glucose load of
1.5 g/kg administered via IP injection. Tail blood was taken 0, 15, 60,
and 120 min after administering glucose, and blood glucose levels
were determined using a OneTouch II glucose meter (Lifescan, USA).
2.4. Determination of myocardial apoptosis and myocardial infarct size
Myocardial apoptosis was determined by terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL) staining and
caspase-3 activity as described in our previous study [24,25].
Myocardial infarct size was determined by Evans blue-2,3,5-triphenyl
tetrazolium chloride (TTC) double staining methods [21].
2.5. Determination of cardiac function
Cardiac functionwas determined by echocardiography aswell as left
ventricular catheterization methods 24 h after reperfusion before the
chest was reopened, as described in previous studies [4].
2.6. Nitric oxide and nitrotyrosine content
Concentrations of nitrites (NO2−) and nitrates (NO3−), the stable
end products of nitric oxide (NO), were determined at the end of
reperfusion in the ventricular tissue by a NO colorimetric assay kit
(BioVision, Inc., California). The values of cardiac NO production were
expressed as the total nitrate and nitrite levels. Cardiac nitrotyrosine, a
footprint of peroxynitrite was measured with chemiluminescence
detection (Millipore, Billerica, MA, USA) according to the manufacturer's
instruction [5].
2.7. Western blotting
The level of protein expression was analyzed using a Western
blotting assay. In brief, heart tissues were homogenized in ice cold
lysis buffer (Tris 50 mM, NaCl 150 mM, NP40 1%, SOD 0.25%, EDTA
1 mM, NaF 1 mM, Na3VO3 1 mM, PMSF 1 M, Rocheproteinase inhibitor
cocktail); the total protein was measured using a Bradford protein
assay. The lysates were loaded on SDS-polyacrylamide gel and
transferred onto nitrocellulose membranes, which were then
immunoblotted with respective antibodies. Quantiﬁcation of Western
blots was obtained by multiplying the area and intensity of each band
using Image J software. The nuclear–cytoplasmic fraction of heart tissue
was conducted using the NE-PER Nuclear and Cytoplasmic Extraction
Reagent kit (Thermo, Fisher Scientiﬁc, Rockford, IL, USA).
2.8. RNA immunoprecipitation
RNA immunoprecipitationwasdone as describedbefore [19,26]. The
RNA in the immunoprecipitated complex and the RNA in the previously
saved input fraction were extracted. Speciﬁc primers used to detect
the presence of FoxO1 mRNAs were synthesized as follows: sense
5′-ttgttacatagtcagcttg-3′ and antisense 5′-tcactttcctgcccaaccag-3′.
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Differences between 2 groups were compared with Student t-test.
For groups more than 2, differences were compared by analysis of
variance (ANOVA) followed by the Scheffe's correction for post-hoc
t-test comparison. Probabilities of 0.05 or less were considered
statistically signiﬁcant.
3. Results
3.1. Diabetes increased susceptibility to myocardial I/R injury
12-Week-old ob/ob mice presented diabetes mellitus. ob/ob mice
displayed signiﬁcantly greater body and heart weights compared with
age-matched WT mice. The heart size (when normalized to tibial
length) and body fat composition were also signiﬁcantly increased in
ob/obmice in comparisonwithWTmice, as expected (Table 1). Glucose
tolerance and insulin sensitivity were signiﬁcantly impaired in ob/ob
mice when compared with WT controls (P b 0.05, Figs. 1A,B). By
echocardiographic measurement, the average of the end systolic
diameter (LVESD), the end diastolic diameter (LVEDD) and the
ejection fraction (EF%) were comparable to that seen in two groups
under basal condition (Table 1), excluding the dilated cardiomyopathy.
Based on this, when subjected to in vivomyocardial I/R, diabetic ob/ob
mice manifested profoundly greater cardiac injury than WT controls.
MI/R-induced LDH release and infarct size were enlarged in ob/ob
mice (P b 0.05, Figs. 1C,D).
3.2. FoxO1 was over-activated in ob/ob myocardium
The activation of FoxO1 is dependent on its translocation to the
nucleus [27]. The content of FoxO1 in the nucleus would represent the
FoxO1 activity. To determine whether diabetes causes alterations in
FoxO1 levels and activity, the cardiac FoxO1 expression levels in the
nuclei, cytoplasm, and whole-heart lysates from WT and ob/ob mice
hearts were examined (Fig. 2). Total cardiac FoxO1 expression was
signiﬁcantly higher in ob/ob mice than WT animals (P b 0.05). We
extracted the nucleus protein and determined FoxO1 levels both in
the nucleus and cytoplasm. Nuclear FoxO1 in ob/ob mice hearts was
signiﬁcantly increased vs. WT animals, while cytoplasmic FoxO1 in
ob/ob mice hearts was signiﬁcantly decreased as compared to WT
animals (both P b 0.05; Figs. 2B,C). These results demonstrated that
cardiac FoxO1 is over-activated under conditions of diabetes.
3.3. Excess nitrosative stress and ER stress in ob/ob hearts
FoxO1 is a major inducer of iNOS in the heart [16]. iNOS induced
nitrosative stress contributes to myocardial apoptosis during I/R [5].
We next hypothesized that FoxO1 over-activation would promote
iNOS expression and result in nitrosative stress in the diabetic heart.
Indeed, iNOS expression was signiﬁcantly increased in the ob/obmice
heart (P b 0.05, Fig. 3A), There was no change in eNOS expression inTable 1
General features WT or ob/obmice (12-week-old).
WT ob/ob
Body weigh (g) 26.1 ± 0.2 44.8 ± 1.03⁎
Heart weigh (mg) 119.7 ± 2.02 144.8 ± 1.79⁎
Tibial length (mm) 17.83 ± 0.28 17.88 ± 0.32
HW/TL (mg/mm) 6.71 ± 0.17 8.1 ± 0.14⁎
Body fat composition (%) 11.88 ± 0.21 71.36 ± 4.3⁎
Heart rate (bpm) 501 ± 25 495 ± 34
End diastolic dimension (mm) 3.98 ± 0.07 4.12 ± 0.09
End systolic dimension (mm) 2.50 ± 0.06 2.54 ± 0.08
EF (%) 61.52 ± 1.3 59.4 ± 1.4
Mean ± SEM.
⁎ P b 0.05 vs.WT, n = 5 per group.cardiac tissues obtained from ob/obmice, whereas eNOS phosphoryla-
tion was reduced (P b 0.05). Total NO production was also markedly in-
creased in diabetic hearts (P b 0.05, Fig. 3B), resulting in a markedly
enhanced nitrotyrosine formation as evidenced by a N1.8-fold increase
in nitrotyrosine content in the ob/ob cardiac tissue (Fig. 3C sham
group). These data showed that there was signiﬁcant nitrosative stress
in ob/obmyocardium. To determine whether such nitrosative stress in
ob/ob mice would increase the vulnerability of diabetic hearts to I/R
injury, we further treated ob/ob mice with 1400W (selective iNOS
inhibitor, 2 mg/kg) or M40401 (a peroxynitrite scavenger, 0.25 mg/kg)
10 min before reperfusion. As summarized in Fig. 3, treatment with
1400W or M40401 effectively blocked excess nitrotyrosine content
from iNOS-induced protein nitration in MI/R ob/obmice cardiac tissue.
Similarly, cardiomyocyte apoptosis, represented by caspase-3 activity,
was more severe in ob/ob comparing toWTmyocardiumwhen subject-
ing toMI/R treatment. Administration of 1400WorM40401 reduced the
caspase-3 activity in ob/ob myocardium encountering I/R (P b 0.05,
Fig. 3D). It is noteworthy that despite the blockage of excess nitrosative
stress from iNOS, treatment with 1400W or M40401 effectively, rather
than completely, reduced additional cardiomyocyte apoptosis in ob/ob
animals (Fig. 3D). These results demonstrate that blocking iNOS activity
or scavenging peroxynitrite partially improved hearts against
MI/R-induced cardiomyocyte apoptosis in ob/obmice, and further sug-
gest that there are other potential mechanisms involved in accelerating
MI/R injury observed in diabetic heart.
Previously research suggests that the excessive ER stress transmitted
pro-apoptotic signals and resulted in cellular apoptosis [9]. Further-
more, there is emerging evidence that over-activation of FoxO1 is
intertwined with excessive ER stress [16]. We next compared the ER
stress level in WT and ob/obmice hearts. Three key molecular sensors
are involved in the ER stress pathway, protein kinase RNA (PKR)-like
ER kinase (PERK), eIF2α, and C/EBP homologous protein (CHOP).
Phosphorylation of PERK induces CHOP-mediated apoptotic signaling,
and mediates phosphorylation of eIF2α and subsequent cell death
pathway. The ER stress could be represented by the level of CHOP
and the phosphorylation of PERK and eIF2α [8]. We found that the
expression of CHOP, and the phosphorylation of PERK and eIF2α
were all up-regulated in ob/ob myocardium comparing to the WT
one (P b 0.05). But, treatment with the aforementioned 1400W or
M40401 did not change the ER stress level in ob/ob hearts (Fig. 4A).
Moreover, treating with the ER stress inhibitor, SAL, did not affect the
enhanced nitrosative stress in ob/ob hearts (P b 0.05, Fig. 4B). It was
showed that the ER stress related cleaved-caspase-12 was exacerbated
in diabetic MI/R hearts, and inhibited by SAL treatment (P b 0.05,
Figs. 4C,D). But, treatment of SAL partially, rather than completely,
reduced MI/R-induced caspase-3 activity in diabetic MI/R hearts
(P b 0.05, Fig. 4E). Combined with the above-mentioned data in
nitrosative stress, these results showed that both the nitrosative stress
and ER stress mediated the ischemic intolerance of diabetic hearts.3.4. Down-regulation of FoxO1 improved the tolerance of diabetic heart
to I/R injury
We conﬁrmed that nitrosative and ER stress mediated the increased
vulnerability of diabetic ob/ob myocardium to I/R injury. FoxO1 is the
upstream regulated factor of both stresses [16]. FoxO1 over-activation
in diabetic hearts may engage both harmful stresses to induce
cardiomyocyte apoptosis. To obtain more evidence to support our
hypothesis, we knocked down FoxO1 level in ob/ob mice hearts.
After intramyocardial injection of FoxO1 speciﬁc siRNA into the LV
wall of ob/ob hearts, the level of cardiac FoxO1 expression was
decreased (Figs. 5A,B). Accordingly, the knockdownof FoxO1 effectively
inhibited the iNOS expression (P b 0.05, Fig. 5C) and nitrotyrosine
content in ob/obmyocardium (P b 0.05, Fig. 5F). Also, knocking down
FoxO1 inhibited the ER stress level represented by decreased ER stress
Fig. 1. Diabetes increased susceptibility to myocardial I/R injury. Glucose tolerance and insulin sensitivity were assessed in wild type (WT) and ob/obmice. (A) Intraperitoneal glucose
tolerance test (IPGTT) and area under the curve in IPGTT; (B) insulin tolerance test (ITT) and area under the curve in ITT (n = 6 per group. *P b 0.05 vs.WT). WT and ob/obmice were
subjected to a 30-minute coronary artery ligation followed by a 4-hour reperfusion in vivo; plasma lactate dehydrogenase (LDH) levels (C) andmyocardial infarct size (D) were detected
(n = 6 per group. *P b 0.05 vs.WT; #P b 0.05 vs.WT+ MI/R).
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myocardium (both P b 0.05, Figs. 5D,E).
We further examine the cardiac protective effects of FoxO1
knockdown on I/R injury. Knockdown of FoxO-1 didn't impactFig. 2. FoxO1 overactivation in the myocardium of ob/ob mice. The hearts of wild type
(WT) and ob/obmicewere isolated, and nuclear proteinwas extracted.Nuclear, cytoplasm
and total lysates were applied to Western blotting to determine the relative levels of
FoxO1 in nuclear, cytoplasm and total protein. (A) Representative gel blots depicting
relative levels of (B) nuclear FoxO1, (C) cytoplasmic FoxO1 and (D) total FoxO1 in WT
and ob/ob hearts (n = 6 per group. *P b 0.05 vs.WT).cardiac function under basal conditions. 30 min of ischemia followed
by 24 h of reperfusion resulted in impaired cardiac function. ob/ob
manifested signiﬁcantly enhanced functional impairment post-MI/R
(P b 0.05, Fig. 6A). Knockdown of cardiac FoxO1 obviously ameliorated
left ventricular ejection fraction post-MI/R (P b 0.05, Fig. 6A), while
control siRNA injection was ineffective. Along with cardiac function,
the infarct size of ob/obmice was 2.5-fold larger than that of WT mice
(Fig. 6B). However, knocking down FoxO1 obviously reduced infarct
size by 44% in ob/ob mice (P b 0.05, Fig. 6B), while control siRNA
injection had no apparent discrepancy in myocardial infarction
compared to ob/ob hearts (Fig. 6B). These results suggested that
over-activation of FoxO1 in ob/obmyocardiummediated the ‘excess’
injury in ob/ob myocardium after subjecting to I/R.
3.5. QKI5 up-regulation reduced FoxO1 and prevented diabetic hearts
against I/R injury
The data above demonstrated that FoxO1 mediated the increased
nitrosative and ER stresses, and consequently I/R injury in diabetic
ob/ob myocardium, but the upstream mechanism of FoxO1 over-
activation was not observed in ob/ob hearts. Our previous studies
have demonstrated that the RNA binding protein QKI5 inhibits the
expression and activation of FoxO1 in cardiomyocytes [20]. We
then tested a hypothesis that the lack of QKI5may increase FoxO1 ac-
tivation in diabetic hearts in vivo, and thus render cardiomyocytes
more susceptible to I/R injury. First, the expression level was
determined by a signiﬁcant down-regulation of QKI5 in ob/ob
myocardium (Fig. 7A). Second, the upregulation of QKI5 by
intramyocardial injection of Ad-QKI5 in an ob/ob heart availably
inhibited the FoxO1 overexpression, resulting in a decrease of iNOS,
GRP78 expression and p-IRE1α level (P b 0.05, Fig. 7B). Third,
I/R-induced cardiomyocyte excessive apoptosis in ob/ob myocardium
was observed to be inhibited by the overexpression of QKI5
Fig. 3.Nitrosative stress in themyocardium of ob/obmice. The hearts of wild type (WT) and ob/obmice were isolated, and homogenized. (A) iNOS, eNOS expression and phosphorylation
of eNOS and (B) total content of nitric oxide were assessed (n= 6 per group. *P b 0.05 vs.WT). WT and ob/obmice were subjected to a 30-minute coronary artery ligation followed by a
4-hour reperfusion in vivo; 1400W (a selective iNOS inhibitor) and M40401 (a peroxynitrite scavenger) or vehicle was administered by i.p. injection 10 min before reperfusion,
respectively. Myocardial nitrosative stress (measured by nitrotyrosine content) and cardiomyocyte apoptosis (measured by caspase-3 activity) were detected (n = 8 per group.
*P b 0.05 vs.WT sham; **P b 0.01 vs.MI/R +WT vehicle; #P b 0.05 vs MI/R + ob/ob vehicle; †P b 0.05 vs.MI/R +WT 1400W or WT M40401, respectively).
Fig. 4.Endoplasmic reticulum(ER) stress in themyocardiumof ob/obmice. (A) Representative gel blots depicting the levels of p-PERK, p-eIF2α and CHOP inwild type (WT) and ob/obmice
hearts with or without 1400W or M40401 treatment. (B) The ob/ob animals were treated by SAL (ER stress inhibitor) or vehicle; normal WT mice were used as control. Myocardial
nitrotyrosine content wasmeasured (n= 6 per group. *P b 0.05 vs.WT). (C)WT and ob/obmice were subjected to a 30-minute coronary artery ligation followed by a 4-hour reperfusion
in vivo, SAL or vehicle was administered by i.p. injection 10min before reperfusion, respectively. Myocardial caspase-12 expression (D) and caspase-3 activity (E) were compared
(n = 8 per group. *P b 0.05 vs. MI/R + WT vehicle; #P b 0.05 vs MI/R + ob/ob vehicle; †P b 0.05 vs. MI/R + WT SAL).
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Fig. 5. The regulation of nitrosative and endoplasmic reticulum(ER) stresses by FoxO1 in themyocardiumof ob/obmice. (A) The ob/ob animalswere subjected to intramyocardial injection
of FoxO1 siRNA (20 μg), control siRNAor vehicle; normalWTmicewere used as control. Quantiﬁcation showing the relative expression of (B) FoxO1, (C) iNOS, (D) p-IRE1α and (E)GRP78.
(F) Myocardial nitrotyrosine content was measured (n = 6 per group. *P b 0.05 vs.WT; #P b 0.05 vs. ob/ob vehicle).
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proved cardiac functional recovery in an ob/ob heart (P b 0.05, Fig. 7D),
while control adenovirus (Ad-EGFP) injection failed to increase cardiac
ejection fraction. In ex vivo perfused mouse hearts, we found that
the myocardial infarct was signiﬁcantly larger in ob/ob hearts than in
WT hearts. QKI5 overexpression exerted directly cardioprotection in
ob/ob myocardium, as evidenced by the reduced myocardial infarctFig. 6. FoxO1 knockdown improved the tolerance of diabetic heart to I/R injury. The ob/ob ani
vehicle, 48 h before ischemia (30 min)/reperfusion (4-hour) treatment. WT MI/R mice were u
of myocardial infarct size expressed as a percent of total ischemic–reperfused area (area-at-rissize (P b 0.05, Fig. 7E). Consistent with our previous ﬁndings, QKI5 re-
ducedmyocardial FoxO1 expression and exerts cardioprotective effects.
Collectively, these in vivo experimental results provide evidence
that the loss of QKI5 is an important cause of FoxO1 over-activation
in ob/ob hearts, and subsequently magniﬁed nitrosative stress and
ER stress. Most importantly, recovery with QKI5 in diabetic hearts
markedly attenuated MI/R injury.mals were treated by intramyocardial injection of FoxO1 siRNA (20 μg), control siRNA or
sed as control. (A) Cardiac function was determined by echocardiography. (B) Summary
k, AAR) (n = 6 per group. *P b 0.05 vs.MI/R +WT; #P b 0.05 vs.MI/R + ob/ob vehicle).
Fig. 7. QKI5 upregulation reduced FoxO1 expression and cardiomyocyte apoptosis after ischemia/reperfusion in diabetic hearts. (A) Representative gel blots depicting QKI5 protein
expression in wild type (WT) and ob/obmice hearts (n = 6 per group; *P b 0.05 vs. WT). (B) The ob/ob animals were subjected to intramyocardial injection of adenovirus encoding-
QKI5 (Ad-QKI5), Ad-EGFP or vehicle; normal WT mice were used as control. After 48 h, the myocardial QKI5, FoxO1, iNOS, GRP78 and p-IRE1α expression were measured. (C) WT and
treated ob/obmice were subjected to a 30-minute ischemia followed by a 4-hour reperfusion in vivo. TUNEL assay was performed to evaluate the effects of QKI5 upregulation on MI/R
induced cardiomyocyte apoptosis. (D) Cardiac function was determined by echocardiography. (E) The percent of infarct size of isolated WT and ob/ob hearts with or without QKI5
upregulation (n = 6 per group. *P b 0.05 vs.MI/R +WT; #P b 0.05 vs.MI/R + ob/ob vehicle).
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To verify the negative regulation of FoxO1 by QKI5, we next deter-
mined the possible mechanism of QKI5-mediated repression of FoxO1.
Associated with the decreased FoxO1 protein levels, the mRNA levels
of FoxO1 were markedly reduced by QKI5 in vivo overexpression in an
ob/obheart (P b 0.05, Fig. 8A). In order to detect the interaction between
QKI5 and FoxO1, an RNA co-immunoprecipitation experiment was per-
formed. Primary culture of neonatal cardiomyocytes was transfected
with pcDNA3.1(+)-EGFP-QKI5 for 24 h, and total cellular extracts
were then incubated with either an anti-EGFP or a nonspeciﬁc antibody(IgG) (Fig. 8B). By RT-PCR analysis, the anti-EGFP immunoprecipitate
contained FoxO1 mRNA whereas the one with non-speciﬁc IgG did
not (Fig. 8 C). We found that overexpression of QKI5 inhibited the
mRNA and protein levels of FoxO1 (Fig. 8 D). To verify whether
QKI post-transcriptionally regulates the mRNA stability of FoxO1,
a transcription inhibitor (actinomycin D) was used to block the
transcription initiation in cardiomyocytes infected with Ad-QKI5.
Ad-EGFP was used as control virus. Cardiomyocytes were harvested
at different time points, and real-time PCR was employed to deter-
mine the decaying rate of FoxO1 mRNA. As shown in Fig. 8E, the
half-life of FoxO1 mRNA was shortened in QKI5 overexpression.
Fig. 8.QKI5 repressed FoxO1 expression. (A) FoxO1mRNA levels in theWT and ob/ob hearts with orwithout QKI5 overexpression (n=5 per group; *P b 0.05 vs.MI/R+WT; #P b 0.05 vs.
MI/R+ ob/ob vehicle). (B) The association of QKI5 and FoxO1was detected by RNA immunoprecipitation. Culture of cardiomyocyteswere seeded in 100-mmdishes and transfectedwith
recombinant adenoviruses expressing EGFP-tagged QKI5 for 24 h and treated with formaldehyde to cross-link protein to RNA. Cells were lysed and incubated with either anti-EGFP or
nonspeciﬁc antibodies (IgG) and protein A Sepharose. Cytoplasmic extract without antibody incubation was saved as an ‘input’ sample. The immunoprecipitated RNAs were isolated
and FoxO1mRNAswere ampliﬁed by PCR. A nonspeciﬁc antibody was used as a negative control (IgG). (C) RT-PCR and (D)Western blottingwere performed to detect FoxO1 expression
in cardiomyocytes with QKI5 overexpressing. (E) Half-life of FoxO1 in cardiomyocytes with or without QKI overexpressing. 5 mg/ml actinomycin D was added to the cardiomyocytes.
At the indicated time points, RNAs were isolated, and the mRNA concentrations of FoxO1 and actin were determined by real-time PCR. The relative amount of FoxO1 mRNA without
actinomycin D treatment was set to 100%, and the percentage of FoxO1 mRNA treated with actinomycin D was calculated accordingly (n = 3 per group. *P b 0.05 vs. Ad-EGFP).
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FoxO1 mRNA.
4. Discussion
The potential molecular mechanism responsible for the increased
vulnerability of diabetic hearts to ischemic injury and the resultant
higher mortality has not been established. In this study, we provide
direct evidence linking QKI5 deﬁciency to FoxO1 overactivation in
the hearts of ob/ob mice. We have proved that QKI5 repressed FoxO1
expression via decreasing its mRNA stability in cardiomyocytes.
We have provided additional evidence that over-activation of FoxO1
possessed detrimental properties on diabetic myocardium. FoxO1
aggravated I/R injury via induction of nitrosative stress and ER stress,
highlighting the role of FoxO1 in I/R injury of diabetic myocardium.
Last but not the least, QKI5 up-regulation could inhibit FoxO1-
mediated nitrosative and ER stresses in ob/ob myocardium. Targeting
QKI-mediated repression of FoxO1 may serve as a novel strategy to
reduce diabetic patient mortality in those with ischemic heart disease.
As one of the signal transduction and activation of RNA (STAR)
family members, QKI exerts its function by mediating the upstream
kinase signals to directly modulate various RNA metabolism processes,
including pre-mRNA splicing, mRNA export, mRNA stability and protein
translation [28]. QKI is abundantly expressed in the brain and heart. The
role of QKI in the nervous system has been well characterized, but its
function in the cardiovascular system is still poorly understood. The de-
ﬁciency of QKI was correlated with the reduction of transcriptional
genes which were critical for blood vessel development, highlighting
the link between abnormal QKI expression and cardiovascular system
dysfunction [29]. Although recent research has implied that QKI is a crit-
ical regulator of VSMC physiological function and vascular repair [30],
the additional roles of QKI in diabetic hearts remain to be discovered.Whether aberrant QKI expression occurs in diabetic myocardium and
what are the possible cellular and physiological consequences remain
unexplored. A bipartite consensus sequence NACUAAY-N1-20-UAAY
was designated as a QKI response element (QRE) and as many as 1430
new mRNA targets were predicted to be QKI direct targets [31]. FoxO1
mRNAwas among these predicted targets [19,20]. The qk gene produces
several alternative splicing variants and encodes 3 major QKI isoforms,
namely QKI5, -6 and -7, respectively. Connecting to our previous
study, we ﬁrst demonstrated the anti-apoptotic effects of QKI5 in
cultured cardiomyocytes and the underlying mechanism was involved
in the repression of FoxO1 [20]. The present study reports that QKI5 is
deﬁcient in diabetic myocardium and FoxO1 is the downstream target
of cardiac QKI5 during diabetes. We thereupon hypothesized that an
abnormal QKI5 level might contribute to the dysregulation of FoxO1
activation and subsequent myocardial injury in diabetic hearts. Our
results showed that ob/ob hearts expressed a very low level of QKI5.
Furthermore, the up-regulation of QKI5 reduced diabetes-induced
FoxO1 expression, along with subsequent myocardial NS stress, ER
stress, and cardiomyocyte apoptosis in ob/ob animals. Our present
data again provided evidence that QKI5 inhibited the expression and
activation of cardiac FoxO1 in vivo. We demonstrate for the ﬁrst
time that QKI5 is a natural molecular factor that inhibits cardiac FoxO1
overexpression in diabetic cardiac tissue, and thus attenuates the
vulnerability of diabetic hearts to ischemic injury.
FoxO1 has important roles in systemic homeostasis. FoxO1 is over-
activated under conditions of nutrient excess, insulin resistance and
ischemia, which can result in metabolic disturbances and cell death
pathway activation in respective tissues [16]. FoxO1 participates in the
regulation of all types of cell death seen during insulin resistance and
diabetes. Although FoxO1 has a well deﬁned role in the induction of
apoptosis, whether this mode of programmed cell death contributes
to increased vulnerability in diabetic heart is debated. Previous studies
139W. Guo et al. / Journal of Molecular and Cellular Cardiology 75 (2014) 131–140have demonstrated that both nitric oxide (NO) and superoxide (O2−)
production are increased in diabetic or high-glucose-treated
cardiomyocytes. Peroxynitrite (ONOO−), the reaction product of
superoxide and nitric oxide, is highly cytotoxic. Nitrosative stress,
initiated by excess NO production and mediated by peroxynitrite,
is suggested to be another crucial response that leads to cell death in
diabetic cardiomyocytes besides oxidative stress. Previous studies
suggested that the inhibition of peroxynitrite formation, either by de-
toxifying peroxynitrite or iNOS inhibitors, is able to reduce I/R injury
[32]. Our study presented similar results that inhibition of peroxynitrite
formation attenuated caspase-3 activity in diabetic ob/ob animals [4,5].
ER stress is also involved in cardiac apoptosis in the diabetic rat model
[33]. Investigations have also demonstrated that ER stress induces cell
apoptosis independently from mitochondria- and death receptor-
dependent pathways. ER stress reduces SERCA2a protein leading to LV
diastolic dysfunction in T2D [34]. These experimental data suggested
that ER stress was initiated in the diabetic heart. The present study
suggested that ER stress was involved in the hypersensitivity
of cardiomyocytes to I/R in the diabetic mouse strain, and that
inhibition of ER stress signiﬁcantly attenuated the injury of diabetic
cardiomyocytes when subjected to I/R, which is similar with what
was found in diabetic cardiomyopathy. Although concurrent nitrosative
stress also contributes to the liability to I/R injury of cardiomyocytes in
the diabetic heart, nitrosative stress pathway inhibitors (1400W or
M40401) did not affect the ER stress represented by the activation of
PERK, p-eIF2α, IRE1α, GRP78 and CHOP in an ob/ob heart, suggesting
that there is no cross talk between nitrosative stress and ER stress.
However, the ER stresswas demonstrated to be initiated by reactive ox-
ygen species (ROS) and calcium handling [35]. The PERK/ATF4/CHOP
branch of the UPR transmits pro-apoptotic signals. The precise mecha-
nism of ER stress-induced cardiomyocyte apoptosis remains elusive;
however, recent data suggest that suppression of Puma, a member of
Bcl-2 family, prevented both ER stress and I/R-induced cardiomyocyte
loss [36]. Another study suggested that Puma activation was also
mediated by FoxO1 activation in diabetic cardiomyocytes [37].
Combined with our data, FoxO1-mediated ER stress might be trans-
duced by Puma. But the present study did not detail this aspect of the
mechanism. Previous studies suggested that FoxO1 brought about cell
death through its ability to increase the expression of caspases and
cell death receptors, both ofwhich are reported to be augmented during
diabetes. FoxO1 has been shown to directly increase the expression of
some pro-apoptotic proteins like Bim and Puma. A role was also
suggested for FoxO1 in regulating pro-apoptotic BAD, a mechanism
mediated through PP2A [27]. Here, we found that FoxO1 activated
two crucial pathways that lead to cardiomyocyte death, nitrosative
stress and ER stress, establishing new pathways that contribute to
the hypersensitivity to I/R injury of diabetic cardiomyocytes, which
highlights the crucial roles of FoxO1 in post I/R injury of diabetic hearts.
As an RNA-binding protein, QKI post-transcriptionally regulates the
mRNA stability, translation efﬁciency or RNA transportation of target
genes via speciﬁcally binding to the 3′-untranslated region (3′UTR).
Our study observed that QKI5 and FoxO1 were inversely expressed in
cardiomyocytes, and the level of FoxO1 mRNA could be inhibited by
QKI5 overexpression. Our current data demonstrated that QKI5
restrained the expression of FoxO1 via decreasing the mRNA stability
of FoxO1 in cardiomyocytes. Although we demonstrated that QKI5
downregulated FoxO1 by posttranscriptional regulation, the molecular
mechanism for the deﬁcient expression of QKI5 in diabetic hearts
remains to be elucidated. Previous studies demonstrated that QKI
expression is absent or very lowly expressed in colon cancer cells
because of the high methylation of the promoter region [26]. Some
studies reported that global DNA hypermethylation is associated with
aging or diabetes mellitus and increased mortality in cardiovascular
disease [38]. Such intriguing possibilities all warrant direct investiga-
tion. The precise mechanisms responsible for QKI5 deﬁciency are likely
complex and cannot be answered in a single experiment.In conclusion, QKI5 deﬁciency promotes FoxO1mediated nitrosative
stress and ER stress which constitute a novel mechanism for rendering
diabetic hearts more vulnerable to enhanced MI injury. The present
study demonstrates that QKI5 is an endogenous therapy target that
relieves the vulnerability of the diabetic heart to I/R injury. These results
suggest that therapeutic interventions preserving QKI5 expression in
the diabetic patient may further improve patient outcomes after
myocardial infarction.Conﬂict of interest
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